Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Deficit

v3.20.1
Consolidated Statement of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Additional Paid-In-Capital [Member]
Deferred Compensation [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 614 $ 56,523,130 $ (10,125) $ (57,919,096) $ (1,405,477)
Balance, shares at Dec. 31, 2017 613,860        
Common stock grants to independent directors $ 7 287,493 287,500
Common stock grants to independent directors, shares 6,725        
Cardax 2018 Warrant Exchange Offering, net $ 48 1,243,989 1,244,037
Cardax 2018 Warrant Exchange Offering, net shares 48,033        
Common stock grants to service providers 22,500 22,500
Common stock grants to service providers, shares 563        
Stock option exercises $ 1 (1)
Stock option exercises, shares 786       1,000
Deferred compensation 10,125 $ 10,125
Stock based compensation - options 330,146 330,146
Net loss (4,024,222) (4,024,222)
Balance at Dec. 31, 2018 $ 670 58,407,257 (61,943,318) (3,535,391)
Balance, shares at Dec. 31, 2018 669,967        
Common stock grants to independent directors   349,989 350,000
Common stock grants to service providers   16,649 $ 16,650
Stock option exercises, shares        
Stock based compensation - options   341,938 $ 341,938
Restricted stock issuances   244,992 245,000
Issuance of warrants attached to a convertible note   125,545 125,545
Beneficial conversion feature issued on convertible notes   350,446 350,446
Retirement of issued stock   2
Net loss   (5,093,037) (5,093,037)
Balance at Dec. 31, 2019 $ 688 $ 59,836,818 $ (67,036,355) $ (7,198,849)
Balance, shares at Dec. 31, 2019 687,564